Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study

1995 ◽  
Vol 92 (5) ◽  
pp. 351-358 ◽  
Author(s):  
T. Fahlén ◽  
H. L. Nilsson ◽  
K. Borg ◽  
M. Humble ◽  
U. Pauli
Keyword(s):  
Monoamine Oxidase ◽  
Social Phobia ◽  
Clinical Efficacy ◽  
Monoamine Oxidase A ◽  
Serotonin Uptake ◽  
Controlled Study ◽  
Double Blind ◽  
Uptake Inhibitor ◽  
Double Blind Placebo ◽  
Serotonin Uptake Inhibitor

Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study

2001 ◽  
Vol 158 (2) ◽  
pp. 275-281 ◽  
Author(s):  
Michael A. Van Ameringen ◽  
Roger M. Lane ◽  
John R. Walker ◽  
Rudradeo C. Bowen ◽  
Pratap Rao Chokka ◽  
...  
Keyword(s):  
Social Phobia ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Generalized Social Phobia

A Controlled Comparison of Fluoxetine and Amitriptyline in Depressed Out-patients

1987 ◽  
Vol 151 (3) ◽  
pp. 337-340 ◽  
Author(s):  
J. P. R. Young ◽  
A. Coleman ◽  
M. H. Lader
Keyword(s):  
Sleep Disturbances ◽  
Treated Group ◽  
Blind Study ◽  
Serotonin Uptake ◽  
Dry Mouth ◽  
Selective Serotonin ◽  
Double Blind Study ◽  
Double Blind ◽  
Uptake Inhibitor ◽  
Serotonin Uptake Inhibitor

Fluoxetine, a selective serotonin uptake inhibitor (mean dose 73 mg each morning) was compared with amitriptyline (mean dose 122 mg at night) in a double-blind study of 64 depressed out-patients. Fifty patients completed the 6-week trial. The drugs did not differ with respect to psychiatrists' ratings, but amitriptyline was slightly superior with respect to patients' ratings. The amitriptyline-treated group had complaints of dry mouth and dizziness on standing; the fluoxetine-treated group of sleep disturbances, nausea, and headaches.

Sign in / Sign up

Export Citation Format

Share Document